Medtronic in Asia: Japanese Resolute Integrity sales and the 1st R&D lab in China

Tue, 08/28/2012 - 3:44pm
Mass Device

Medical device giant Medtronic launches its Resolute Integrity drug-eluting coronary stents on the Japanese market and opens its 1st research & development facility in China.

Medtronic's Resolute Integrity stent

Medtronic's Resolute Integrity

Medical device giant Medtronic (NYSE:MDT) is making new moves in Asia, launching commercial sales of its Resolute Integrity stent on the Japanese market and announcing the 1st research & development facility in China.

The Resolute Integrity drug-eluting stent, which won Japanese approval earlier this year with indicated to treat coronary artery disease, made its way onto Japan's market, the world's 2nd largest for medical devices.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.